The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s ...
Medtronic's FDA-approved BrainSense Adaptive DBS system revolutionizes Parkinson's therapy with real-time adjustments for ...
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real ...
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no ...
Shawn Connolly, a former skateboarding professional, follows the directions of Nicholas B. Galifianakis, MD, while testing a ...
Side effects of deep brain stimulation in people to treat Parkinson's may include impulsivity and depression. Biomedical ...